JVMCX
Price
$27.50
Change
+$0.17 (+0.62%)
Updated
Jul 25 closing price
Net Assets
23.06B
TRVHX
Price
$18.63
Change
+$0.14 (+0.76%)
Updated
Jul 25 closing price
Net Assets
1.68B
Interact to see
Advertisement

JVMCX vs TRVHX

Header iconJVMCX vs TRVHX Comparison
Open Charts JVMCX vs TRVHXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$27.50
Change+$0.17 (+0.62%)
VolumeN/A
Net Assets23.06B
Nuveen Mid Cap Value I
Price$18.63
Change+$0.14 (+0.76%)
VolumeN/A
Net Assets1.68B
JVMCX vs TRVHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMCX vs. TRVHX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a StrongBuy and TRVHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.1B vs. TRVHX (1.68B). TRVHX pays higher dividends than JVMCX: TRVHX (1.60) vs JVMCX (0.00). JVMCX was incepted earlier than TRVHX: JVMCX (14 years) vs TRVHX (10 years). JVMCX (1.88) is less costly to investors than TRVHX (0.58). JVMCX (49.00) and TRVHX (48.00) have comparable annual turnover. JVMCX has a lower initial minimum investment than TRVHX: JVMCX (1000) vs TRVHX (100000). TRVHX annual gain was more profitable for investors over the last year : 4.16 vs. JVMCX (-0.47). JVMCX return over 5 years is better than : 50.96 vs. TRVHX (40.54).
JVMCXTRVHXJVMCX / TRVHX
Total Expense Ratio1.870.58322%
Annual Report Gross Expense Ratio1.880.58324%
Fund Existence14 years10 years-
Gain YTD8.6965.672153%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets23.1B1.68B1,374%
Annual Yield % from dividends0.001.60-
Returns for 1 year-0.474.16-11%
Returns for 3 years17.8414.11126%
Returns for 5 years50.9640.54126%
Returns for 10 years37.38N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXBC34.501.00
+2.99%
Oxford Bank Corporation
JGSMY6.53N/A
N/A
JG Summit Holdings, Inc.
LNTEF16.00N/A
N/A
Lintec Corp.
GENFF0.01N/A
N/A
Genflow Biosciences Plc
SVNDY13.43-0.23
-1.65%
Seven & I Holdings Co., Ltd.